In this meta-analysis of randomized trials involving patients hospitalized with COVID-19, therapeutic-dose anticoagulation ...
1. Local progression-free survival at 3 years was 84.3% in the SBRT group vs 67.3% in the RFA group, with HR 0.45 (significant). 2. HR for progression-free survival (HR 0.76) and overall survival (HR ...
Coffee consumption correlates with better cognitive performance in patients with a high incidence for stroke 1. In this ...
Pembrolizumab plus radiotherapy and surgery significantly improved disease-free survival. 2. Grade 3 or higher adverse events ...